Introduction: Prenatally androgenized (PA) female rhesus monkeys share metabolic abnormalities in common with polycystic ovary syndrome (PCOS) women. Early gestation exposure (E) results in insulin resistance, impaired pancreatic b-cell function and type 2 diabetes, while late gestation exposure (L) results in supranormal insulin sensitivity that declines with increasing body mass index (BMI). Objective: To determine whether PA females have altered body fat distribution. Design: Five early-treated PA (EPA), five late-treated PA (LPA) and five control adult female monkeys underwent somatometrics, dual-X-ray absorptiometry (DXA) and abdominal computed tomography (CT). Five control and five EPA females underwent an intravenous glucose tolerance test to assess the relationship between body composition and glucoregulation. Results: There were no differences in age, weight, BMI or somatometrics. LPA females had B20% greater DXA-determined total fat and percent body fat, as well as total and percent abdominal fat than EPA or control females (Pp0.05). LPA females also had B40% more CT-determined non-visceral abdominal fat than EPA or control females (Pp0.05). The volume of visceral fat was similar among the three groups. EPA (R 2 ¼ 0.94, Pp0.01) and LPA (R 2 ¼ 0.53, P ¼ 0.16) females had a positive relationship between visceral fat and BMI, although not significant for LPA females. Conversely, control females had a positive relationship between non-visceral fat and BMI (R 2 ¼ 0.98, Pp0.001). There was a positive relationship between basal insulin and total body (R 2 ¼ 0.95, Pp0.007), total abdominal (R 2 ¼ 0.81, Pp0.04) and visceral (R 2 ¼ 0.82, Pp0.03) fat quantities in EPA, but not control females. Conclusions: Prenatal androgenization in female rhesus monkeys induces adiposity-dependent visceral fat accumulation, and late gestation androgenization causes increased total body and non-visceral fat mass. Early gestation androgenization induces visceral fat-dependent hyperinsulinemia. The relationship between the timing of prenatal androgen exposure and body composition phenotypes in this nonhuman primate model for PCOS may provide insight into the heterogeneity of metabolic defects found in PCOS women.
Introduction
Prenatally androgenized (PA) female rhesus monkeys, a nonhuman primate model of polycystic ovary syndrome (PCOS), exhibit metabolic abnormalities similar to those found in PCOS women. [1] [2] [3] Female monkeys exposed to testosterone excess in early gestation (early-treated) exhibit insulin resistance, impaired pancreatic b-cell function and type 2 diabetes, while those exposed in late gestation (late-treated) develop supranormal insulin sensitivity that declines with increasing body mass index (BMI). [3] [4] [5] Women with PCOS have increased upper body obesity and visceral fat, independent of total body mass, [6] [7] [8] [9] similar to findings in PA female rhesus monkeys exposed to testosterone excess during early gestation. 10 Previous studies in rhesus monkeys indicate that increased abdominal adiposity may be a potential mechanism for the observed metabolic abnormalities in early-treated PA (EPA) females. 3, 10 Whether late-treated females harbor similar alterations in body composition is unknown. Moreover, the effect of altered body composition on glucoregulation in PA females has not been elucidated. The purposes of this study were to examine body composition using dual-X-ray absorptiometry (DXA) and total abdominal computed tomography (CT) and to assess the relationship of body fat distribution with glucoregulatory dynamics.
Materials and methods

Animals
Fifteen adult female rhesus monkeys (Macaca mulatta) were used in this study and were maintained at the National Primate Research Center, University of Wisconsin, Madison (WNPRC) according to standard protocol. 11 Measures of body composition Somatometrics. Animals were anesthetized with an intramuscular (i.m.) injection of ketamine hydrochloride (7 mg/kg) and xylazine (0.6 mg/kg). Xylazine was partially reversed with yohimbine (0.06 mg/kg intravenous (i.v.)). Somatometric measurements were performed immediately before DXA scans. Measurements of body weight, body length, body and limb circumference, and skinfold thickness were performed by a single operator (STB). All assessments were performed with the animal in a supine position with the exception of abdominal and chest circumferences, which were accomplished with the animal in a right lateral recumbent position. Skinfold thickness was determined using a Lange caliper, as previously reported. 10 BMI was calculated as body weight (kg) divided by the square of the crown rump length (m 2 ).
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Dual-X-ray absorptiometry. DXA was performed on anesthetized animals immediately after somatometric measurements. DXA has a precision (CV%) of o4% for total body and regional composition in rhesus monkeys. 18 Animals were placed in a supine position for scanning with DXA scanner model DPX-L (GE/Lunar Corp., Madison WI, USA). Images were acquired and analyzed with pediatric software (versions 1.5e and 4.0a, respectively) to determine total body and abdominal lean and fat mass, as reported previously. 18 Each scan lasted B15 min. The abdominal region of interest was defined by area between the thoracic (T) 12-lumbar (L) 1 interspace and the L6-L7 interspace. To compare CT and DXA adipose volumes, DXA-derived adipose mass was converted to volume by dividing by the average density of triglyceride (0.9 kg/l). The mean and variance of the Hounsfield units (HUs) in these three regions were recorded. The s.d. and means from these three regions were averaged together respectively to yield an average HU mean and s.d. To estimate the lower limit of adipose tissue density, 20 s.d. were added to the mean HU. Using this method, the average upper limit of adipose tissue density was À4671.5 HU (mean7s.e.m.) and was similar in the three groups (EPA, À4572.6; LPA, À5071.5 and control (C), À4473.2). The HU value calculated for the upper limit of adipose tissue by this method visually corresponded to slightly less than the nadir of the distribution overlap between nonadipose tissue HU and adipose tissue HU. The HU value selected for the upper limit of adipose tissue density was set at -200. Each abdominal slice between T12-L1 and the top of the sacrum was analyzed for total and visceral fat. First, visceral fat area was assessed by 'painting' the abdominal region inside the peritoneum with a mouse-driven cursor, while excluding colon contents and adipose tissue posterior to the longitudinal axis of the kidneys and great vessels. The adipose regions posterior to the kidneys and great vessels and outside the peritoneal lining was then painted and the surface area was recorded as the total adipose tissue. The surface areas of each slice were multiplied by the slice thickness (0.5 cm) to yield a volume of adipose tissue. Non-visceral (or subcutaneous) adipose was calculated as the difference between the total and visceral compartments. Between-group differences were assessed based on the adipose volume between the T12-L1 interspace and the top of the sacrum. The adipose volume from T12-L1 through L6-7 assess by CT was used to correlate abdominal adipose volume with the same abdominal region assessed by DXA. Eighteen CT images were re-analyzed by the same operator (CMB) for both total and visceral adipose area to provide an estimate of within-operator variability. CT measurements of total and visceral fat were highly repro- Statistical methods Summary measures derived from FSIGT. The tolbutamidemodified minimal model (version 3.0, RN Bergman) was used to generate estimates of insulin sensitivity (S I ) and glucose effectiveness (S G ). S I reflects the ability of insulin to promote glucose uptake and to inhibit hepatic glucose production. S G reflects insulin-independent glucose uptake and suppression of hepatic glucose production. Further measures derived from the FSIGT included basal glucose (Gb; mean of the four prechallenge glucose values, À15, À10, À5 and -2 min), basal insulin (Ib; mean of the four prechallenge insulin values), acute insulin response to glucose (AIRg; average increase in insulin above basal at 2-4 min, post challenge), and disposition index (DI; b-cell compensation index; product of S I and AIRg).
Statistical analyses. Baseline characteristics in Table 1 were analyzed by ANOVA (Systat v.5.2. 1, Evanston, IL, USA),
Prenatal androgen alters body composition CM Bruns et al except for menstrual cycle duration. The latter analysis was performed using Kruskal-Wallis because of lack of normality in the data. 19 All body composition variables were compared using analysis of covariance (ANCOVA; Systat Version 5.2.1) with type of female (EPA, LPA, control) as a factor and BMI as a covariate after homogeneity of slopes was confirmed.
There was an interaction between BMI and non-visceral fat by CT scan (Po0.04) excluding ANCOVA for the latter parameter. Post hoc analyses, using Fisher's least significant difference (LSD) tests, were performed when the overall ANCOVA P-value was p0.05. Plots of residuals showed a homogeneous variance across the range of BMI. Multiple linear regression analysis was used to assess the relationships between body composition variables and FSIGT variables. The correlation between CT and DXA measurements of abdominal fat was assessed by linear regression. Intraobserver variability was examined using linear regression. A P-value p0.05 was considered significant. Data are presented as mean7s.e.m.
Results
Somatometrics
There were no significant between-group differences in abdominal circumference or skinfold thickness measurements (data not shown).
Dual-X-ray absorptiometry
Total and percent body fat mass, as well as abdominal and percent abdominal fat mass, as determined by DXA, were greater in LPA compared to EPA and control females (Pp0.05; Table 2 ). Total and abdominal lean mass was similar for all three groups, although LPA females had a lower proportion of total body and abdominal lean mass than EPA and control females (Pp0.05; Table 2 ).
Computed Tomography CT-determined volumes of visceral fat were similar for all three female groups ( Table 2) . Late-treated PA females exhibited a larger volume of non-visceral (subcutaneous) abdominal fat than EPA or control females (Pp0.05; Table 2 ).
Association between CT-determined body composition and BMI EPA females preferentially deposit visceral fat at BMIs above the mean for normal females (Figure 1a) . A similar, parallel relationship is exhibited in LPA females, although not statistically significant (P ¼ 0.16). If, however, the LPA female with excessive visceral fat (929 cm 3 ) relative to her BMI (B35 kg/m 2 ; Figure 1a) is removed from the analysis, the LPA females exhibit (Po0.008) an almost identical positive relationship (R 2 ¼ 0.98; y ¼ 89x-2515) between visceral fat and BMI as found in EPA female monkeys. In contrast, control females do not significantly accumulate visceral fat with increasing BMI, but instead accumulate non-visceral fat with increasing BMI (Figure 1b) , unlike both PA female groups.
Correlation between measures derived from basal glucose and insulin and DXA-and CT-determined estimates of body composition Basal serum insulin levels in EPA females were positively correlated with total body (Figure 2a ), total abdominal ( Figure 2b ) and visceral ( Figure 2c ) fat quantities, while similar relationships between Ib and body composition in control females did not occur. The associations between Ib and body fat parameters among EPA females were reexamined using a rank-based method (Spearman rank-order correlation) that is robust to outliers. In this analysis, the strength of these associations persisted (Ib vs total body fat, r s ¼ 0.90, P ¼ 0.04; vs total abdominal fat, r s ¼ 1.00, Po0.0001; vs visceral fat, r s ¼ 0.80, P ¼ 0.10). There were no Prenatal androgen alters body composition CM Bruns et al statistically significant relationships between S G , S I , DI, Gb or AIRg and body composition variables in the three female groups (data not shown).
Validation of a single-slice determination of abdominal fat compartments The amount and proportion of visceral fat volumes in the single L4-5 abdominal slice were highly correlated with the total visceral fat volume of the entire abdomen (amount: Analysis of covariance utilizing this combined CT-and DXAderived measure yielded results similar to that using the direct measurement of total abdominal visceral fat by CT (Pp0.05). Similarly, the product of the percent non-visceral fat in the L4-5 slice and the DXA-derived total abdominal fat were highly correlated with the CT-derived total abdominal non-visceral fat (Pp0.05).
Discussion
This study confirms and extends our previous body composition study of PA female rhesus monkeys 10 showing preferential accumulation of abdominal visceral fat in EPA female monkeys, further demonstrating that preferential visceral fat accumulation depends upon increasing BMI. The lack of difference in absolute fat accumulation (regardless of BMI) between EPA females and controls in our current study vs our previous one 10 . 10 Given preferential accumulation of visceral fat with increasing BMI in EPA females, we might not have noted an increase in visceral fat in the EPA group because their BMI range was lower than reported previously. 10 Further, in support of prenatal androgen exposure reprogramming BMI-dependent visceral fat accumulation, LPA females demonstrate a similar positive relationship to that shown by EPA females. In this latter regard, while data on sex differences in visceral fat accumulation in rhesus monkeys are lacking, sex differences in visceral fat accumulation in humans would be consistent with the notion of prenatal androgen programming. 20 Men demonstrate a positive relationship between visceral fat and BMI throughout the adult male BMI range. In contrast, women only do so when BMI reaches overweight or obese categories. 20 Since maximal BMI values in our control females reach over 40 kg/m 2 ( Figure 1a ), well short of the obese range for female rhesus monkeys in our colony, 21 the lack of association between visceral fat and BMI in control females in this study would be consistent with the absence of obesity. EPA females also exhibit a significant correlation between Ib and total body fat, total abdominal fat and visceral fat, agreeing with data from PCOS women showing an increase in visceral fat with fasting serum insulin levels. 8 Whether inter-individual differences among EPA and LPA females may reflect differences in fetal exposure or sensitivity to gestational androgen excess, 5 genotypic differences in androgen receptor 22 or androgen biosynthetic enzyme expression 23 remains to be determined. Body composition analyses by DXA and CT indicate that LPA female rhesus monkeys have increased total body fat, percent total body fat, total abdominal fat and non-visceral (subcutaneous) abdominal fat compared to early-treated and control monkeys. In other words, visceral and nonvisceral abdominal fat accumulations are different metabolic consequences of early-and late-gestation exposure to androgen excess, respectively. Both gestational treatments induce preferential accumulation of abdominal adiposity. They just vary in the intra-abdominal site at which the accumulation occurs. Interestingly, early-gestation testosterone programming results in additional adiposity-dependent glucoregulatory dysfunction, indicated by correlations between Ib and total body fat, total abdominal fat and visceral fat. In addition, early androgenization results in impaired pancreatic b-cell function 3 and increased incidence of type 2 diabetes. 4 We do not yet have enough data to conclude if late-gestation testosterone excess affects glucoregulation, but we have previously reported a negative relationship between S I and BMI in this female group. 3 Such differences in body fat distribution, based upon timing of gestational testosterone excess, extend our understanding of PCOS phenotypic variation from differential exposure to prenatal androgen excess 5 and could additionally contribute to the heterogeneity in metabolic consequences of PCOS. The association of accumulated upper body fat with metabolic complications (including insulin resistance) is widely documented in humans (reviewed by Lebovitz and Banerji 24 ), and is an important clinical characteristic of women with PCOS (reviewed by Venkatesan 25 ). The increased insulin resistance in PCOS women can be accounted for by increased abdominal fat. 26 Even though insulin resistance in PCOS women can be independent of obesity, obesity and PCOS act synergistically to affect adversely glucose homeostasis. 27 In these regards, our current findings that early gestation androgen excess programs both hyperinsulinemia from adiposity-dependent insulin resistance and preferential accumulation of visceral adiposity in the same animals, 5,10,28 strongly implicate fetal programming of metabolic dysfunction in our nonhuman primate model for PCOS and suggest a fetal origin for this syndrome.
